FREQUENCY OF POTENTIAL DRUG-DRUG INTERACTIONSCOOPER JW JR; WELLINS I; FISH KH JR et al.1975; J. AMER. PHARM. ASS.; U.S.A.; DA. 1975; VOL. 15; NO 1; PP. 24-27 (4P.); BIBL. 17REF.Article

INTERAZIONI FARMACEUTICHE E BIOFARMACEUTICHE TRA FARMACI = INTERACTIONS PHARMACEUTIQUES ET BIOPHARMACEUTIQUES DES MEDICAMENTS1973; BOLL. SOC. ITAL. FARM. OSP.; ITAL.; DA. 1973; VOL. 19; NO 2; PP. 89-103; BIBL. 9REF.Serial Issue

ADDITIVE EFFECT OF PENTOBARBITAL AND HALOTHANE TO INHIBIT SYNTHESIS OF LUNG PROTEINSRANNELS DE; ROAKE GM; WATKINS CA et al.1982; ANESTHESIOLOGY; ISSN 0003-3022; USA; DA. 1982; VOL. 57; NO 2; PP. 87-93; BIBL. 17 REF.Article

AU SUJET DES INTERACTIONS MEDICAMENTEUSESLAPORTE J.1972; PROGR. MED.; FR.; DA. 1972; VOL. 100; NO 10; PP. 361-371 (8 P.); BIBL. 1 P.Serial Issue

EFFECT OF SALICYCLIC ACID ON THE ACTIVITY OF BETAMETHASONE-17,21-DIPROPIONATE IN THE TREATMENT OF ERYTHEMATOUS SQUAMOUS DERMATOSESELIE R; DUROCHER LP; KAVALEC EC et al.1983; JOURNAL OF INTERNATIONAL MEDICAL RESEARCH; ISSN 0300-0605; GBR; DA. 1983; VOL. 11; NO 2; PP. 108-112; BIBL. 28 REF.Article

THE QUINIDINE-DIGOXIN INTERACTION IN PATIENTS WITH IMPAIRED RENAL FUNCTIONFICHTL B; DOERING W; SEIDEL H et al.1983; INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY AND TOXICOLOGY (1980); ISSN 0174-4879; DEU; DA. 1983; VOL. 21; NO 5; PP. 229-233; BIBL. 22 REF.Article

DRUG INTERACTIONS IN OPHTHALMOLOGYDAVIDSON SI.1975; TRANS. OPHTHALMOL. SOC. U.K.; G.B.; DA. 1975; VOL. 95; NO 2; PP. 277-280; BIBL. 17 REF.; (OXFORD OPHTHALMOL. CONGR. 60. PROC.; OXFORD; 1975)Conference Paper

INTERACTIONS OF ANTIEPILEPTIC DRUGS.KUTT H.1975; EPILEPSIA; PAYS-BAS; DA. 1975; VOL. 16; NO 2; PP. 393-402; BIBL. 2 P. 1/2Article

INTERACTIONS OF CNS DRUGS PSYCHOTHERAPEUTIC AGENTS. THE ANTIANXIETY DRUGSHARTSHORN EA.1975; DRUG INTELLIG. CLIN. PHARM.; U.S.A.; DA. 1975; VOL. 9; NO 1; PP. 26-35; BIBL. 2P.Article

DRUG INTERACTIONS IN ANAESTHESIAGROGONO AW.1974; BRIT. J. ANAESTH.; G.B.; DA. 1974; VOL. 46; NO 8; PP. 613-618; BIBL. 38 REF.Article

LES INTERACTIONS THERAPEUTIQUESLAROCHE C; VIGNE J; GREGOIRE J et al.1974; CAH. MED.; FR.; DA. 1974; VOL. 15; NO 13; PP. 829-839; BIBL. 28REF.; (ACTUAL. THER. RAPP. PRESENTES ASSISES NATL.; NICE; 1974)Conference Paper

CHECK-LIST TO POTENTIAL CLINICALLY IMPORTANT INTERACTIONSAVERY GS.1973; DRUGS; SWITZ.; DA. 1973; VOL. 5; NO 3; PP. 187-211Serial Issue

EFFECT OF L-VALINE ON RENAL EXCRETION, BLOOD CONCENTRATIONS AND TOXICITY OF CYCLOLEUCINE IN MICE = EFFET DE LA L-VALINE SUR LA SECRETION RENALE, LES CONCENTRATIONS SANGUINES ET LA TOXICITE DE LA CYCLOLEUCINE CHEZ DES SOURISRUELIUS HW; GREGORY FJ; KIRKMAN SK et al.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 11; PP. 1379-1383; BIBL. 18REF.Serial Issue

INTERACTIONS OF PSYCHOTROPIC DRUGS IN THE ELDERLY = INTERACTION DES DROGUES PSYCHOTROPES CHEZ LES PERSONNES AGEESEISDORFER C; FANN WE.1973; POSTGRAD. MED.; U.S.A.; DA. 1973; VOL. 53; NO 3; PP. 182-186; BIBL. 14REF.Serial Issue

METHODES POUR L'INTENSIFICATION DU POTENTIEL DES ANESTHESIES LOCALESFILIPESCU A; SPIRESCU I; NITESCU M et al.1972; AGRESSOLOGIE; FR.; DA. 1972; VOL. 13; NO 4; PP. 213-216; BIBL. 1REF.Serial Issue

CENTRAL EFFECTS OF PROSTAGLANDIN E₂ AND INDOMETHACIN ON INSULIN-STIMULATED GASTRIC ACID SECRETION IN ANAESTHETISED RATSPUURUNEN J.1983; ACTA PHARMACOLOGICA ET TOXICOLOGICA; ISSN 0001-6683; DNK; DA. 1983; VOL. 52; NO 4; PP. 318-320; BIBL. 11 REF.Article

ARZNEIMITTEL-INTERAKTIONEN = INTERACTIONS MEDICAMENTEUSESMEYER UA.1976; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1976; VOL. 106; NO 12; PP. 424-426; ABS. ANGL.; BIBL. 11 REF.Article

LES INTERACTIONS DES ANTIBIOTIQUES ANTIBACTERIENS AVEC D'AUTRES CATEGORIES DE MEDICAMENTSNEUMAN M.1973; FEMME ET ENFANT; FR.; DA. 1973; VOL. 7; NO 3; PP. 173-176Serial Issue

ASPECTS PHARMACOCINETIQUES ET BIOCHIMIQUES DES INTERACTIONS MEDICAMENTEUSESJINDRA A; KAMENIKOVA L; SIPAL Z et al.1973; FARM. OBZ.; CESKOSL.; DA. 1973; VOL. 13; NO 1; PP. 51-55; ABS. RUSSE ANGL. ALLEM.; BIBL. 15REF.Serial Issue

ENHANCEMENT OF THE DNA CROSS-LINKING ACTIVITY OF MELPHALAN BY MISONIDAZOLE IN VIVO = STIMULATION DE L'ACTIVITE DE PONTAGE DU DNA DU MELPHALAN PAR LE MISONIDAZOLE IN VIVOMURRAY D; MEYN RE.1983; BRITISH JOURNAL OF CANCER; ISSN 0007-0920; GBR; DA. 1983; VOL. 47; NO 2; PP. 195-203; BIBL. 1 P.Article

DOSE- AND TIME-RELATED EFFECT OF TROLEANDOMYCIN ON METHYLPREDNISOLONE ELIMINATIONSZEFLER SJ; BRENNER M; JUSKO WJ et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 166-171; BIBL. 12 REF.Article

MULTIPLE DRUG THERAPY: A GENERAL-PRACTICE SURVEYBOWTLE WJ; HUNTER K.1980; J. CLIN. HOSP. PHARM.; GBR; DA. 1980; VOL. 5; NO 3; PP. 203-208; BIBL. 10 REF.Article

MEDICATIONS PRE-OPERATOIRES ET RISQUES ANESTHESIQUESBOULLIE JC; WINCKLER C.1976; OUEST MED.; FR.; DA. 1976; VOL. 29; NO 4; PP. 323-328Article

DIPHENYLHYDANTOIN. BLOCKING OF LEVODOPA EFFECTS = DIPHENYLHYDANTOINE. BLOCAGE DES EFFETS DE LA L-DOPAMENDEZ JS; COTZIAS GC; MENA I et al.1975; ARCH. NEUROL.; U.S.A.; DA. 1975; VOL. 32; NO 1; PP. 44-46; BIBL. 30REF.Article

THE ELECTROCHEMISTRY OF SOME DRUG INTERACTIONSECKERT G; GUTMANN F.1975; J. ELECTROANAL. CHEM. INTERFACIAL ELECTROCHEM.; NETHERL.; DA. 1975; VOL. 62; NO 1; PP. 267-272; BIBL. 23REF.Article